Amneal Pharmaceuticals, Inc. (AMRX) Financials

AMRX Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 3.8 billion 3.7 billion
March 31, 2026 3.5 billion 3.6 billion
Dec. 31, 2025 3.7 billion 3.7 billion
Sept. 30, 2025 3.6 billion 3.7 billion

AMRX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -64.9 million 10.4 million
March 31, 2026 -42.6 million 8.8 million
Dec. 31, 2025 87.1 million 8.2 million
Sept. 30, 2025 103.4 million 8.2 million

AMRX Net Income

No data available :(

AMRX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 127.6 million 2.6 billion 121.5 million
March 31, 2026 197.7 million 2.6 billion 124.7 million
Dec. 31, 2025 310.9 million 2.6 billion 102.4 million
Sept. 30, 2025 201.2 million 2.6 billion 112.0 million

AMRX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 328.1 million
March 31, 2026 328.9 million
Dec. 31, 2025 324.8 million
Sept. 30, 2025 324.8 million

AMRX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 45.6 million 41.1 million 148.7 million -
March 31, 2026 13.9 million 38.4 million 138.9 million -
Dec. 31, 2025 43.2 million 34.8 million 146.5 million -
Sept. 30, 2025 15.1 million 63.4 million 137.8 million -

AMRX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 796.2 million 461.7 million
March 31, 2026 722.5 million 402.4 million
Dec. 31, 2025 814.3 million 517.1 million
Sept. 30, 2025 784.5 million 510.5 million

AMRX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

AMRX

Price: $20.50

52 week price:
9.49
20.50

Payout Ratio Range:
-2087.11%
788.51%

Earnings Per Share: 0.48 USD

P/E Ratio: 38.46

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 1.8 million

Market Capitalization: 5.6 billion

Links: